Search - tctmd.com

Displaying 581 - 595 of 595

Sort: Relevancy | Date

Presentation NY Valves 2024

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

Presenter: Eduardo A. Arias

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Presenter: Bo Yang

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Presenter: Nirat Beohar

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Never Use a Mechanical Valve

Presenter: Anelechi Anyanwu

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Recommend a Mechanical Valve

Presenter: Michael J. Mack

June 05, 2024

Presentation NY Valves 2024

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Presenter: Masaaki Nakase

June 05, 2024

Presentation NY Valves 2024

Case Presentation: A Healthy 55 Year-Old With Severe AS

Presenter: Michael I. Brener

June 05, 2024

Video

» Live Case

Live Case 10- Aortic Valve-in-Valve with Leaflet Modification_LIVE Case Presentation- Electrosurgery (BASILICA+) - Emory University Hospital, Atlanta, GA

July 2, 2025

Video

» Interview

Bicuspid Aortic Valve Controversies: The Next Steps

June 24, 2024

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

» Interview

Preemptive (Early) TAVI in Severe and Moderate AS Patients

June 24, 2024

Video

» On Record

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

August 6, 2025

Video

» Interview

Introducing Target AS

June 24, 2024

Video

» Interview

Advances in the Management of AR

June 24, 2024

Advertisement

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

3 Reasons Why… I Would Never Use a Mechanical Valve

3 Reasons Why… I Would Recommend a Mechanical Valve

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Case Presentation: A Healthy 55 Year-Old With Severe AS

Live Case 10- Aortic Valve-in-Valve with Leaflet Modification_LIVE Case Presentation- Electrosurgery (BASILICA+) - Emory University Hospital, Atlanta, GA

Bicuspid Aortic Valve Controversies: The Next Steps

Treatment of AS in Young Patients

Preemptive (Early) TAVI in Severe and Moderate AS Patients

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

Introducing Target AS

Advances in the Management of AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content